Table III.
Comparison of age, pre-existing patient comorbidities and Rockwood frailty score between triage categories with patients assessed as high risk (A and B) and low risk (C and D) of a poor outcome from COVID-19
| High risk (A and B) | Low risk (C and D) | P | |
|---|---|---|---|
| N | 65 | 28 | |
| Age, median [IQR] | 72 [62, 83] | 53.5 [44, 57] | <0.001 |
| Sex, % male | 35 (53.8) | 18 (64.3) | 0.481 |
| Comorbidities | |||
| Cardiovascular disease (%) | 36 (55.4) | 6 (21.4) | 0.005 |
| Cerebrovascular disease (%) | 11 (16.9) | 0 (0.0) | 0.049 |
| Chronic respiratory disease (%) | 11 (16.9) | 2 (7.1) | 0.357 |
| Type II diabetes mellitus (%) | 18 (27.7) | 4 (14.3) | 0.259 |
| Chronic kidney disease (%) | 8 (12.3) | 0 (0.0) | 0.124 |
| Malignancy (%) | 10 (15.4) | 1 (3.6) | 0.205 |
| Other comorbidities (%)∗ | 13 (20.0) | 3 (10.7) | 0.430 |
| No known comorbidities (%) | 2 (3.1) | 7 (25.0) | 0.004 |
| Rockwood frailty score (%) | <0.001 | ||
| 1–3 | 19 (32.8) | 24 (85.7) | |
| 4–6 | 23 (39.7) | 4 (14.3) | |
| 7–9 | 16 (27.6) | 0 (0.0) | |
IQR, interquartile range.
∗
Dementia, alcoholism, inflammatory bowel disease.